Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Avita Medical (AVMXY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 205,066
  • Shares Outstanding, K 31,646
  • Annual Sales, $ 1,280 K
  • Annual Income, $ -12,810 K
  • 60-Month Beta 1.46
  • Price/Sales 172.02
  • Price/Cash Flow N/A
  • Price/Book 9.61
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 10/05/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.7450 +38.80%
on 05/01/19
7.1700 -8.15%
on 05/16/19
+1.3660 (+26.17%)
since 04/18/19
3-Month
1.8400 +257.93%
on 02/22/19
7.6700 -14.13%
on 04/08/19
+4.5060 (+216.63%)
since 02/20/19
52-Week
0.8000 +723.25%
on 06/01/18
7.6700 -14.13%
on 04/08/19
+5.7360 (+674.82%)
since 05/18/18

Most Recent Stories

More News
Health Economic Model Published in Advances in Therapy Demonstrates Reduced Cost and Decreased Hospital Stay with the RECELL(R) System

AVITA Medical (ASX: AVH, OTCQX: AVMXY) announced today that the health economic model of the U.S. burn care pathway, developed in collaboration with Biomedical Advanced Research and Development...

AVMXY : 6.6100 (+2.01%)
AVITA Medical Appoints Interim CFO

AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, announced today that Dale A. Sander is resigning as Chief Financial Officer (CFO) to spend more time with his...

AVMXY : 6.6100 (+2.01%)
AVITA Medical to Present at RBC Capital Markets 2019 Healthcare Conference

AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, announced that management will present at the RBC Capital Markets 2019 Healthcare Conference in New York. The...

AVMXY : 6.6100 (+2.01%)
AVITA Medical Third Quarter Fiscal 2019 Quarterly Cash Flow Report and Company Update

--Strong U.S. product sales of A$2.2 million for third quarter of Fiscal 2019 were double second quarter sales

AVMXY : 6.6100 (+2.01%)
AVITA Medical Announces Presentation at ABA Meeting Highlighting Results of Study Using RECELL(R) System to Treat Third-Degree Burns in Pediatric Patients

--The publication of the RECELL System pivotal trial in the treatment of second-degree burns was selected as a top journal publication for 2018

AVMXY : 6.6100 (+2.01%)
AVITA Medical RECELL(R) System Health Economic Data Project USD $28 Million in Annual Savings at a Single Major Burn Center Versus Standard of Care

--Patients with burns covering more than 50% of their bodies treated using the RECELL System in combination with widely meshed autografts healed as quickly as patients with smaller burn injuries with the...

AVMXY : 6.6100 (+2.01%)
AVITA Medical to Present at Cowen and Company Health Care Conference

AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, announced that management will present at the Cowen and Company 39th Annual Health Care Conference in Boston....

AVMXY : 6.6100 (+2.01%)
AVITA Medical Announces Ten RECELL(R) System Presentations at the American Burn Association (ABA) Annual Meeting

--Developer of RECELL System, Professor Fiona Wood, to present long-term clinical outcomes of over 3,500 patients treated with RECELL

AVMXY : 6.6100 (+2.01%)
Avita Medical Announces Collaboration with COSMOTEC, an M3 Group Company, to Commercialize the RECELL(R) System in Japan

AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, announced that it has collaborated with COSMOTEC, an M3 Group company, to market and distribute the RECELL(R)...

AVMXY : 6.6100 (+2.01%)
Avita Medical Half-Year Financial Report for Fiscal 2019

AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, announced that it filed today with the ASX its Appendix 4D - Half-Year Report for the six months ended 31 December...

AVMXY : 6.6100 (+2.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More Share

Trade AVMXY with:

Key Turning Points

2nd Resistance Point 7.1667
1st Resistance Point 6.8233
Last Price 6.6100
1st Support Level 6.2933
2nd Support Level 6.1067

See More

52-Week High 7.6700
Last Price 6.6100
Fibonacci 61.8% 5.0457
Fibonacci 50% 4.2350
Fibonacci 38.2% 3.4243
52-Week Low 0.8000

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar